News search
 Research 23 Jan 2024 The most potent genetic risk factor for Alzheimer disease, APOE4, is associated with an elevated risk of developing subclinical atherosclerosis in middle age, whereas the Alzheimer-protective variant of the same gene, APOE2, protects against subclinical atherosclerosis |
 |
 About the CNIC 24 Jun 2022 Juan Domingo Gispert López, head of the Barcelonaβeta Brain Research Center and CNIC (Spanish National Centre for Cardiovascular Research) researcher |
 About the CNIC 18 May 2022 The project will examine long-term changes in plasma biomarkers of neuronal injury, neuroinflammation, and Alzheimer's disease in participants in the PESA-CNIC-SANTANDER study who have undergone imaging studies to map brain metabolism. The goal of the project is to determine how cardiovascular risk factors during midlife impact brain function |
 About the CNIC 6 Jul 2021 This project represents a major development in the need to implement early cardiovascular intervention strategies that are capable of reducing the incidence of AD at the advanced ages in Alzheimer's disease |
 Research 15 Feb 2021 Among the modifiable cardiovascular risk factors showing a close association with reduced brain metabolism, the research team found that the most important is hypertension |
 About the CNIC 15 Dec 2020 The BioClotAD project, coordinated by CNIC scientist Dr Marta Cortés Canteli, has been selected by the EU Joint Programme – Neurodegenerative Disease Research (JPND) |
 About the CNIC 11 Feb 2020 María Ángeles Moro leads the CNIC's Neurovascular Pathophysiology Laboratory. |
 Research 9 Oct 2019 Treatment of mice for 12 months with the anticoagulant drug dabigatran prevented memory loss and preserved cerebral circulation |
 About the CNIC 30 May 2017 Los resultados permitirán avanzar en el conocimiento de la interacción entre los diversos factores de riesgo de ambas enfermedades |
